BSEM (BioStem Technologies) Change In Inventory: $0.0 Mil (TTM As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSEM BioStem Technologies Inc BSEM
36 GF Score
Price $4.01
! 3 Warning Signs
View Full Analysis

What is BioStem Technologies Change In Inventory?

BioStem Technologies BSEM +4.59% 36 Change In Inventory is $0.0 Mil as of Sep. 2025. GuruFocus rates BSEM with a GF Score™ of 36/100. The stock has 3 warning signs investors should review.

BioStem Technologies's change in inventory for the quarter that ended in Sep. 2025 was $0.0 Mil. It means BioStem Technologies's inventory stayed the same from Dec. 2024 to Sep. 2025 .

BioStem Technologies's change in inventory for the fiscal year that ended in Dec. 2024 was $-1.2 Mil. It means BioStem Technologies's inventory increased by $1.2 Mil from Dec. 2023 to Dec. 2024 .

BioStem Technologies's Total Inventories for the quarter that ended in Sep. 2025 was $2.7 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. BioStem Technologies's Days Inventory for the quarter that ended in Sep. 2025 was 172.53.

Inventory Turnover measures how fast the company turns over its inventory within a year. BioStem Technologies's Inventory Turnover for the quarter that ended in Sep. 2025 was 0.53.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. BioStem Technologies's Inventory-to-Revenue for the quarter that ended in Sep. 2025 was 0.22.

BioStem Technologies  (OTCPK:BSEM) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

BioStem Technologies's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=2.2765/1.204*365 / 4
=172.53

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

BioStem Technologies's Inventory Turnover for the quarter that ended in Sep. 2025 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=1.204 / 2.2765
=0.53

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

BioStem Technologies's Inventory to Revenue for the quarter that ended in Sep. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=2.2765 / 10.473
=0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioStem Technologies Change In Inventory Related Terms

BioStem Technologies Change In Inventory Historical Data

* Premium members only.

The historical data trend for BioStem Technologies's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioStem Technologies Change In Inventory Chart

BioStem Technologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.09 0.21 -0.14 -0.26 -1.17

BioStem Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Sep21 Dec21 Mar22 Sep22 Dec22 Mar23 Sep23 Dec23 Sep24 Dec24 Sep25
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.16 0.00 0.00 0.00
BSEM
36GF Score
BioStem Technologies Inc BSEM
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioStem Technologies Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of $0.0 Mil mean?
BioStem Technologies (BSEM) has a Change In Inventory of $0.0 Mil as of Sep. 2025. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for BioStem Technologies and its competitors.
Is BioStem Technologies' Change In Inventory too high?
BioStem Technologies' current Change In Inventory is $0.0 Mil. Overall, BioStem Technologies has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does BioStem Technologies' Change In Inventory compare to XLO and TCRX?
BioStem Technologies' Change In Inventory of $0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for BioStem Technologies and its competitors. BioStem Technologies's current Change In Inventory is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioStem Technologies stock overvalued right now?
BioStem Technologies (BSEM) has a current Change In Inventory of $0.0 Mil. The current Change In Inventory is $0.0 Mil. BioStem Technologies' overall GF Score™ is 36/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For BioStem Technologies (BSEM), the current Change In Inventory is $0.0 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioStem Technologies Business Description

Address 2836 Center Port Circle, Pompano Beach, FL, USA, 33064
BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.
36GF Score

Get the complete analysis for BSEM

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.01
Price